微电生理股价跌5.07%，华泰柏瑞基金旗下1只基金重仓，持有37.4万股浮亏损失45.26万元

Group 1 - The core viewpoint of the news is the performance and financial status of Shanghai MicroPort CardioFlow Medtech Co., Ltd., which saw a stock price decline of 5.07% to 22.66 CNY per share, with a total market capitalization of 10.664 billion CNY [1] - The company specializes in innovative medical devices for electrophysiology intervention and ablation treatment, with its main revenue sources being catheter products (71.77%), other products (20.22%), equipment (7.24%), and leasing services (0.77%) [1] - The company was established on August 31, 2010, and went public on August 31, 2022 [1] Group 2 - Huatai-PB Healthcare A Fund holds a significant position in MicroPort CardioFlow, with 374,000 shares, unchanged from the previous period, representing 2.97% of the fund's net value [2] - The fund has reported a floating loss of approximately 452,600 CNY today [2] - The fund was established on June 25, 2018, with a current size of 241 million CNY and has achieved a year-to-date return of 34.54% [2]